Nasdaq
$3.91▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $581.6MShares out 1.500M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
15- 10.16Pre-market26.10.16 22:11425Other#●●●#●●●
MIMEDX GROUP, INC.
MiMedx Group received a 'Second Request' for additional information and documentary materials from the FTC on October 15, 2026, regarding its proposed acquisition of Sanara MedTech. This action extends the waiting period under the HSR Act, and the completion of the merger remains subject to the expiration or termination of this period and other closing conditions.…more
$3.91+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16Pre-market26.10.16 22:018-KKey event
MIMEDX GROUP, INC.
MiMedx Group and Sanara MedTech have received a 'Second Request' for additional information and documentary materials from the FTC regarding their proposed merger. This request extends the waiting period under the HSR Act, and the completion of the merger remains subject to compliance with this regulatory review and other closing conditions.…more
$3.91+0.00%vs prev closeView filingShare - 9.8Pre-market26.09.08 13:15filedEFFECTOther
MIMEDX GROUP, INC.
The registration statement (Form S-3) filed by MiMedx Group, Inc. was declared effective by the SEC on September 4, 2026. This effectiveness allows the company to proceed with the issuance of securities for future capital raising purposes.…more
$3.91+0.00%vs prev closeView filingShare
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14After-hours26.10.15 05:01#●●●
MIMEDX to Report Q3 2026 Financial Results on October 28
MIMEDX announced that it will release its third quarter 2026 financial results after the market close on October 28, 2026. This is a standard earnings announcement schedule and is considered neutral for the stock.…more
$3.91+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.23After-hours26.09.24 05:01
●●●●●●●● ●●●●● ●●●●●●
A U.S. District Court vacated the FDA's classification of AXIOFILL, ordering the agency to reconsider its determination regarding the product's regulatory status. While this ruling addresses key legal challenges, the company must now engage with the FDA for further review.…more
$3.91+0.00%vs prev close - 9.8Pre-market26.09.08 21:00
●●●●●●●● ●●●●● ●●●●●●
MIMEDX management will participate in upcoming investor conferences to conduct one-on-one meetings. This is a routine investor relations activity with no immediate impact on the stock price.…more
$3.91+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report